Patents by Inventor Linda Greensmith

Linda Greensmith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HEAT SHOCK PROTEIN INDUCERS AND FRONTOTEMPORAL DISORDERS
    Publication number: 20200085812
    Abstract: The present invention relates to a bioactive agent that increases the intracellular concentration and/or activity of one or more heat shock proteins, including Hsp70, for use in the treatment of frontotemporal disorders.
    Type: Application
    Filed: May 24, 2018
    Publication date: March 19, 2020
    Inventors: Thomas Kirkegaard Jensen, Linda Greensmith
  • USE OF A HYDROXIMIC ACID HALIDE DERIVATIVE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20150126551
    Abstract: The invention relates to the use of a chemical substance selected from the group consisting of N-'2-hydroxy-3-(1piperidinyl)-propoxy]-1-pyridine-1-oxide-3-carboximidoyl chloride, the optically active enantiomers and the mixtures of enantiomers thereof and pharmaceutically acceptable salts of the racemic and optically active compounds in the preparation of a pharmaceutical composition for the treatment or prevention of neurodegenerative diseases.
    Type: Application
    Filed: January 12, 2015
    Publication date: May 7, 2015
    Inventors: Linda Greensmith, Geoffrey Burnstock, Rudolf Urbanics
  • Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
    Patent number: 8962604
    Abstract: The invention relates to the use of a chemical substance selected from the group consisting of N-?2-hydroxy-3-(1-piperidinyl)-propoxyl 1-pyridine-1-oxide-3-carboximidoyl chloride, the optically active enantiomers and the mixtures of enantiomers thereof and pharmaceutically acceptable salts of the racemic and optically active compounds in the preparation of a pharmaceutical composition for the treatment or prevention of neurodegenerative diseases.
    Type: Grant
    Filed: September 12, 2011
    Date of Patent: February 24, 2015
    Assignee: Orphazyme ApS
    Inventors: Linda Greensmith, Geoffrey Burnstock, Rudolf Urbanics
  • USE OF A HYDROXIMIC ACID HALIDE DERIVATIVE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20120115908
    Abstract: The invention relates to the use of a chemical substance selected from the group consisting of N-?2-hydroxy-3-(1-piperidinyl)-propoxyl 1-pyridine-1-oxide-3-carboximidoyl chloride, the optically active enantiomers and the mixtures of enantiomers thereof and pharmaceutically acceptable salts of the racemic and optically active compounds in the preparation of a pharmaceutical composition for the treatment or prevention of neurodegenerative diseases.
    Type: Application
    Filed: September 12, 2011
    Publication date: May 10, 2012
    Inventors: Linda Greensmith, Geoffrey Burnstock, Rudolf Urbanics
  • Use Of A Hydroximic Acid Halide Derivative In The Treatment Of Neurodegenerative Diseases
    Publication number: 20080039497
    Abstract: The invention relates to the use of a chemical substance selected from the group consisting of N-?2-hydroxy-3-(1-piperidinyl)-propoxyl !-pyridine-1-oxide-3-carboximidoyl chloride, the optically active enantiomers and the mixtures of enantiomers thereof and pharmaceutically acceptable salts of the racemic and optically active compounds in the preparation of a pharmaceutical composition for the treatment or prevention of neurodegenerative diseases.
    Type: Application
    Filed: October 25, 2004
    Publication date: February 14, 2008
    Inventors: Linda Greensmith, Geoffrey Burnstock, Rudolf Urbanics